Physician profile
Michael D Dabbah
NPI 1184673477
$13,017.97
in general payments reported to CMS, 2019-2025
13 companies · $174 in 2025
The $174 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $746 · 2020: $476 · 2021: $275 · 2022: $252 · 2023: $264 · 2024: $11K · 2025: $174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $10K · Travel and Lodging: $586 · Food and Beverage: $455.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $10,227.24 |
| Travel and Lodging | $586.39 |
| Food and Beverage | $454.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $11,388.02 | 2019-2024 | Yukon Oct Spinal System, Serrato |
| Arthrex, INC. | $541.30 | 2024 | |
| Abbott Laboratories | $365.91 | 2019-2022 | |
| Medtronic, INC. | $190.49 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Boston Scientific Corporation | $140.37 | 2020-2025 | Infinion 16 |
| Supreme Orthopedic Systems, LLC | $131.47 | 2024 | |
| Globus Medical, INC. | $117.51 | 2023 | Excelsiusgps Robotic Navigation System |
| Baxter Healthcare | $41.51 | 2020 | |
| Amgen INC. | $25.76 | 2021 | |
| Radius Health, INC. | $22.65 | 2025 | |
| Arteriocyte Medical Systems, INC. | $19.93 | 2019 | |
| Native Surgical, LLC | $19.03 | 2025 | |
| Smith+Nephew, INC. | $14.02 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Dabbah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.